Christopher Robert Sudfeld, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tanzania | 85 | 2024 | 1407 | 5.450 |
Why?
|
Child Development | 35 | 2024 | 2330 | 4.570 |
Why?
|
Micronutrients | 18 | 2022 | 390 | 3.980 |
Why?
|
Dietary Supplements | 46 | 2024 | 3445 | 3.780 |
Why?
|
HIV Infections | 47 | 2024 | 17569 | 3.270 |
Why?
|
Premature Birth | 15 | 2024 | 1829 | 2.490 |
Why?
|
Cholecalciferol | 6 | 2024 | 557 | 2.140 |
Why?
|
Vitamin D Deficiency | 9 | 2022 | 1388 | 1.880 |
Why?
|
Infant Mortality | 11 | 2024 | 752 | 1.680 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2024 | 2185 | 1.620 |
Why?
|
Growth Disorders | 13 | 2024 | 635 | 1.450 |
Why?
|
Anemia, Iron-Deficiency | 8 | 2022 | 372 | 1.410 |
Why?
|
Mothers | 14 | 2023 | 2209 | 1.390 |
Why?
|
Pregnancy | 62 | 2024 | 30256 | 1.360 |
Why?
|
Tuberculosis, Pulmonary | 5 | 2020 | 843 | 1.360 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 3 | 2021 | 161 | 1.310 |
Why?
|
Nutritional Status | 12 | 2023 | 1628 | 1.300 |
Why?
|
Infant, Low Birth Weight | 7 | 2024 | 871 | 1.300 |
Why?
|
Maternal Nutritional Physiological Phenomena | 5 | 2024 | 395 | 1.290 |
Why?
|
Malnutrition | 9 | 2024 | 632 | 1.280 |
Why?
|
Infant | 75 | 2024 | 36535 | 1.280 |
Why?
|
Vitamins | 15 | 2022 | 1638 | 1.270 |
Why?
|
Rural Population | 20 | 2024 | 2325 | 1.250 |
Why?
|
Anti-Retroviral Agents | 6 | 2024 | 1789 | 1.210 |
Why?
|
Child Nutritional Physiological Phenomena | 5 | 2023 | 294 | 1.160 |
Why?
|
Motor Skills | 4 | 2019 | 523 | 1.130 |
Why?
|
Vitamin A | 10 | 2022 | 611 | 1.120 |
Why?
|
Iron | 12 | 2024 | 1813 | 1.110 |
Why?
|
Vitamin D | 12 | 2022 | 3311 | 1.110 |
Why?
|
Folic Acid | 9 | 2024 | 1337 | 1.100 |
Why?
|
Adolescent Development | 2 | 2021 | 276 | 1.080 |
Why?
|
Calcium, Dietary | 4 | 2024 | 533 | 1.080 |
Why?
|
Developing Countries | 18 | 2024 | 2910 | 1.070 |
Why?
|
Pregnancy Complications | 5 | 2023 | 2973 | 1.060 |
Why?
|
Infant, Newborn | 52 | 2024 | 26422 | 1.050 |
Why?
|
Depression | 11 | 2023 | 8230 | 0.980 |
Why?
|
Stillbirth | 6 | 2023 | 381 | 0.970 |
Why?
|
Poverty | 7 | 2021 | 2720 | 0.950 |
Why?
|
Birth Weight | 10 | 2023 | 2121 | 0.920 |
Why?
|
Thinness | 7 | 2023 | 483 | 0.890 |
Why?
|
Infant, Small for Gestational Age | 8 | 2024 | 468 | 0.890 |
Why?
|
CD4 Lymphocyte Count | 10 | 2024 | 2596 | 0.880 |
Why?
|
Cognition | 12 | 2024 | 7073 | 0.850 |
Why?
|
Antiretroviral Therapy, Highly Active | 9 | 2024 | 1903 | 0.850 |
Why?
|
Child Nutrition Disorders | 2 | 2021 | 140 | 0.850 |
Why?
|
Child, Preschool | 57 | 2024 | 42669 | 0.850 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 2 | 2022 | 52 | 0.830 |
Why?
|
Prenatal Care | 5 | 2024 | 1162 | 0.830 |
Why?
|
Anemia | 10 | 2024 | 1514 | 0.820 |
Why?
|
Breast Feeding | 10 | 2024 | 1363 | 0.820 |
Why?
|
HIV Wasting Syndrome | 2 | 2013 | 99 | 0.810 |
Why?
|
Female | 137 | 2024 | 397192 | 0.800 |
Why?
|
Lactation | 5 | 2024 | 392 | 0.790 |
Why?
|
Zinc | 7 | 2024 | 677 | 0.780 |
Why?
|
Wasting Syndrome | 3 | 2021 | 96 | 0.770 |
Why?
|
Measles Vaccine | 2 | 2013 | 79 | 0.750 |
Why?
|
Intelligence | 3 | 2021 | 926 | 0.740 |
Why?
|
Milk, Human | 4 | 2023 | 490 | 0.730 |
Why?
|
Pregnant Women | 5 | 2023 | 576 | 0.720 |
Why?
|
Pregnancy Outcome | 8 | 2023 | 2972 | 0.720 |
Why?
|
Pre-Eclampsia | 4 | 2024 | 1255 | 0.710 |
Why?
|
Double-Blind Method | 18 | 2023 | 12465 | 0.680 |
Why?
|
Opportunistic Infections | 2 | 2013 | 375 | 0.680 |
Why?
|
Income | 4 | 2021 | 1878 | 0.660 |
Why?
|
Humans | 170 | 2024 | 768166 | 0.650 |
Why?
|
Hypercalcemia | 1 | 2022 | 424 | 0.640 |
Why?
|
Unemployment | 2 | 2021 | 211 | 0.630 |
Why?
|
Prospective Studies | 34 | 2024 | 54926 | 0.630 |
Why?
|
Education, Nonprofessional | 1 | 2018 | 31 | 0.610 |
Why?
|
Anti-HIV Agents | 9 | 2024 | 4573 | 0.610 |
Why?
|
Focus Groups | 1 | 2024 | 1460 | 0.600 |
Why?
|
Child | 55 | 2024 | 80917 | 0.590 |
Why?
|
Measles | 2 | 2010 | 180 | 0.580 |
Why?
|
Punishment | 1 | 2018 | 95 | 0.580 |
Why?
|
Young Adult | 43 | 2024 | 60066 | 0.560 |
Why?
|
Viral Load | 7 | 2024 | 3396 | 0.560 |
Why?
|
Pregnancy Trimester, Third | 1 | 2019 | 587 | 0.540 |
Why?
|
Social Support | 2 | 2024 | 2193 | 0.540 |
Why?
|
Health Status | 6 | 2020 | 4091 | 0.530 |
Why?
|
Diarrhea | 7 | 2024 | 1320 | 0.520 |
Why?
|
Alanine Transaminase | 1 | 2019 | 606 | 0.520 |
Why?
|
World Health Organization | 2 | 2019 | 1329 | 0.510 |
Why?
|
Nutrition Policy | 2 | 2019 | 467 | 0.510 |
Why?
|
Morbidity | 8 | 2024 | 1755 | 0.500 |
Why?
|
Calcium | 4 | 2024 | 5792 | 0.490 |
Why?
|
Executive Function | 2 | 2021 | 1401 | 0.480 |
Why?
|
Male | 85 | 2024 | 364719 | 0.480 |
Why?
|
Adult | 64 | 2024 | 223646 | 0.470 |
Why?
|
Weight Gain | 3 | 2024 | 2359 | 0.470 |
Why?
|
Adolescent | 39 | 2024 | 89169 | 0.470 |
Why?
|
Fetal Development | 1 | 2020 | 779 | 0.460 |
Why?
|
Anthropometry | 5 | 2023 | 1346 | 0.460 |
Why?
|
Tuberculosis | 4 | 2022 | 2029 | 0.450 |
Why?
|
Patient Discharge | 6 | 2024 | 3479 | 0.450 |
Why?
|
Growth | 2 | 2016 | 366 | 0.450 |
Why?
|
Cross-Sectional Studies | 29 | 2024 | 26379 | 0.440 |
Why?
|
Aftercare | 4 | 2024 | 916 | 0.440 |
Why?
|
Gestational Age | 3 | 2021 | 3621 | 0.430 |
Why?
|
Peer Group | 2 | 2024 | 700 | 0.430 |
Why?
|
Diet | 7 | 2021 | 8089 | 0.430 |
Why?
|
Qualitative Research | 1 | 2024 | 3140 | 0.430 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2017 | 664 | 0.430 |
Why?
|
Mental Health | 4 | 2020 | 3275 | 0.420 |
Why?
|
Socioeconomic Factors | 15 | 2023 | 7852 | 0.420 |
Why?
|
Research | 1 | 2021 | 1979 | 0.420 |
Why?
|
Vitamin B 12 | 3 | 2020 | 529 | 0.400 |
Why?
|
Herpes Genitalis | 1 | 2013 | 149 | 0.390 |
Why?
|
India | 8 | 2024 | 2334 | 0.390 |
Why?
|
Herpesvirus 2, Human | 1 | 2013 | 191 | 0.390 |
Why?
|
Antibodies, Viral | 2 | 2013 | 3216 | 0.380 |
Why?
|
Ethiopia | 7 | 2022 | 485 | 0.380 |
Why?
|
Vitamin A Deficiency | 4 | 2017 | 88 | 0.380 |
Why?
|
Hemoglobins | 7 | 2022 | 1531 | 0.370 |
Why?
|
Selenium | 1 | 2014 | 418 | 0.360 |
Why?
|
Cohort Studies | 20 | 2024 | 41754 | 0.360 |
Why?
|
Risk Factors | 30 | 2024 | 74944 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 14 | 2024 | 10399 | 0.350 |
Why?
|
Patient Compliance | 1 | 2020 | 2697 | 0.340 |
Why?
|
Health Services Accessibility | 3 | 2024 | 5520 | 0.330 |
Why?
|
Iron, Dietary | 2 | 2023 | 148 | 0.330 |
Why?
|
Infectious Disease Transmission, Vertical | 4 | 2022 | 1354 | 0.330 |
Why?
|
Serum Albumin | 1 | 2013 | 677 | 0.330 |
Why?
|
Prevalence | 15 | 2023 | 15869 | 0.320 |
Why?
|
Infant Nutritional Physiological Phenomena | 4 | 2019 | 352 | 0.310 |
Why?
|
Chickens | 2 | 2021 | 845 | 0.310 |
Why?
|
Pakistan | 3 | 2024 | 299 | 0.310 |
Why?
|
Disease Transmission, Infectious | 1 | 2014 | 560 | 0.300 |
Why?
|
Niger | 3 | 2022 | 38 | 0.300 |
Why?
|
Vaccination | 2 | 2022 | 3437 | 0.290 |
Why?
|
Health Promotion | 2 | 2019 | 2210 | 0.290 |
Why?
|
Urban Population | 5 | 2024 | 2046 | 0.280 |
Why?
|
Weight Loss | 2 | 2022 | 2721 | 0.280 |
Why?
|
Fungi | 1 | 2009 | 345 | 0.280 |
Why?
|
Brazil | 5 | 2021 | 1250 | 0.270 |
Why?
|
Linear Models | 5 | 2021 | 5884 | 0.270 |
Why?
|
Mycoses | 1 | 2009 | 386 | 0.270 |
Why?
|
Liberia | 5 | 2024 | 176 | 0.270 |
Why?
|
Body Height | 6 | 2024 | 1565 | 0.260 |
Why?
|
Developmental Disabilities | 3 | 2019 | 1518 | 0.260 |
Why?
|
Hypertension, Pregnancy-Induced | 2 | 2022 | 529 | 0.250 |
Why?
|
RNA, Viral | 1 | 2014 | 2872 | 0.250 |
Why?
|
Malawi | 4 | 2024 | 312 | 0.250 |
Why?
|
Chad | 1 | 2024 | 9 | 0.240 |
Why?
|
Incidence | 10 | 2020 | 21538 | 0.230 |
Why?
|
Dysentery | 1 | 2024 | 14 | 0.230 |
Why?
|
Meconium Aspiration Syndrome | 1 | 2024 | 30 | 0.230 |
Why?
|
Animal Husbandry | 2 | 2021 | 64 | 0.220 |
Why?
|
Quality Improvement | 1 | 2019 | 3857 | 0.220 |
Why?
|
Age Factors | 11 | 2021 | 18412 | 0.220 |
Why?
|
Africa South of the Sahara | 6 | 2023 | 752 | 0.210 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2019 | 2538 | 0.210 |
Why?
|
Placebos | 2 | 2020 | 1667 | 0.210 |
Why?
|
Child Mortality | 3 | 2024 | 204 | 0.200 |
Why?
|
Maternal Age | 4 | 2019 | 805 | 0.200 |
Why?
|
Fetal Death | 1 | 2024 | 434 | 0.200 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7454 | 0.200 |
Why?
|
Disease Progression | 3 | 2022 | 13671 | 0.190 |
Why?
|
China | 4 | 2021 | 2395 | 0.190 |
Why?
|
Anxiety | 1 | 2017 | 4672 | 0.190 |
Why?
|
Health Behavior | 4 | 2020 | 2650 | 0.190 |
Why?
|
Body Mass Index | 7 | 2024 | 13053 | 0.190 |
Why?
|
Clinical Protocols | 2 | 2017 | 1443 | 0.190 |
Why?
|
Models, Theoretical | 3 | 2021 | 3573 | 0.190 |
Why?
|
Communication | 1 | 2015 | 3905 | 0.180 |
Why?
|
Nutritive Value | 2 | 2021 | 351 | 0.180 |
Why?
|
Sex Factors | 10 | 2022 | 10632 | 0.180 |
Why?
|
Education | 2 | 2021 | 533 | 0.180 |
Why?
|
Peru | 3 | 2019 | 890 | 0.180 |
Why?
|
Treatment Outcome | 11 | 2022 | 65371 | 0.180 |
Why?
|
Infant Nutrition Disorders | 2 | 2018 | 70 | 0.180 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2022 | 293 | 0.180 |
Why?
|
Antidiarrheals | 1 | 2020 | 46 | 0.180 |
Why?
|
Language Development | 2 | 2019 | 183 | 0.180 |
Why?
|
Educational Status | 2 | 2019 | 2515 | 0.180 |
Why?
|
Follow-Up Studies | 12 | 2022 | 39348 | 0.170 |
Why?
|
Azithromycin | 1 | 2021 | 201 | 0.170 |
Why?
|
Cystic Fibrosis | 1 | 2009 | 1294 | 0.170 |
Why?
|
Armenia | 1 | 2020 | 16 | 0.170 |
Why?
|
Growth Hormone | 1 | 2022 | 573 | 0.170 |
Why?
|
Survival Analysis | 3 | 2019 | 10101 | 0.160 |
Why?
|
Eggs | 1 | 2020 | 182 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12077 | 0.160 |
Why?
|
Immunoglobulins | 1 | 2022 | 855 | 0.160 |
Why?
|
BCG Vaccine | 1 | 2022 | 381 | 0.160 |
Why?
|
Maternal Behavior | 1 | 2021 | 307 | 0.160 |
Why?
|
Inflammation | 4 | 2024 | 10873 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 416 | 0.160 |
Why?
|
Longitudinal Studies | 6 | 2024 | 14783 | 0.160 |
Why?
|
Hematologic Tests | 1 | 2020 | 239 | 0.160 |
Why?
|
Intelligence Tests | 1 | 2019 | 504 | 0.150 |
Why?
|
Financial Support | 1 | 2019 | 116 | 0.150 |
Why?
|
Drug Administration Schedule | 3 | 2021 | 4860 | 0.150 |
Why?
|
Administration, Oral | 3 | 2021 | 4030 | 0.150 |
Why?
|
Vietnam | 1 | 2019 | 415 | 0.150 |
Why?
|
Middle Aged | 21 | 2024 | 223492 | 0.150 |
Why?
|
Program Evaluation | 3 | 2024 | 2507 | 0.150 |
Why?
|
Time Factors | 5 | 2021 | 40218 | 0.150 |
Why?
|
Ferritins | 4 | 2022 | 601 | 0.150 |
Why?
|
Quality of Life | 1 | 2020 | 13490 | 0.150 |
Why?
|
Botswana | 2 | 2022 | 1058 | 0.150 |
Why?
|
Mother-Child Relations | 1 | 2021 | 498 | 0.150 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2019 | 225 | 0.150 |
Why?
|
Quality-Adjusted Life Years | 3 | 2012 | 1741 | 0.140 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2019 | 184 | 0.140 |
Why?
|
Proportional Hazards Models | 6 | 2015 | 12543 | 0.140 |
Why?
|
Perinatal Care | 1 | 2020 | 245 | 0.140 |
Why?
|
House Calls | 1 | 2019 | 171 | 0.140 |
Why?
|
Single-Blind Method | 1 | 2021 | 1587 | 0.140 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2022 | 1942 | 0.140 |
Why?
|
Overweight | 3 | 2024 | 2448 | 0.140 |
Why?
|
HIV-1 | 1 | 2014 | 6961 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6526 | 0.130 |
Why?
|
C-Reactive Protein | 3 | 2024 | 3858 | 0.130 |
Why?
|
Psychotherapy, Group | 1 | 2020 | 417 | 0.130 |
Why?
|
Eating | 2 | 2021 | 1542 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2024 | 1397 | 0.130 |
Why?
|
Schools | 2 | 2021 | 1498 | 0.130 |
Why?
|
Postpartum Period | 2 | 2020 | 1198 | 0.120 |
Why?
|
Communication Disorders | 1 | 2015 | 50 | 0.120 |
Why?
|
HIV | 1 | 2022 | 1597 | 0.120 |
Why?
|
School Health Services | 1 | 2019 | 388 | 0.120 |
Why?
|
Motor Skills Disorders | 1 | 2015 | 89 | 0.120 |
Why?
|
Anti-Bacterial Agents | 4 | 2024 | 7477 | 0.120 |
Why?
|
Research Design | 4 | 2019 | 6211 | 0.120 |
Why?
|
Maternal Mortality | 1 | 2017 | 310 | 0.120 |
Why?
|
Body Weight | 2 | 2015 | 4627 | 0.110 |
Why?
|
Communicable Disease Control | 1 | 2021 | 857 | 0.110 |
Why?
|
Community Health Services | 1 | 2019 | 659 | 0.110 |
Why?
|
Lipids | 2 | 2022 | 3343 | 0.110 |
Why?
|
Birth Intervals | 1 | 2014 | 55 | 0.110 |
Why?
|
Salaries and Fringe Benefits | 1 | 2016 | 263 | 0.110 |
Why?
|
Child Care | 2 | 2024 | 126 | 0.110 |
Why?
|
Endemic Diseases | 1 | 2014 | 191 | 0.110 |
Why?
|
Community-Based Participatory Research | 2 | 2019 | 223 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2022 | 874 | 0.110 |
Why?
|
Social Environment | 1 | 2018 | 1012 | 0.110 |
Why?
|
Hepatitis B | 1 | 2019 | 711 | 0.110 |
Why?
|
Sexual Behavior | 2 | 2019 | 2197 | 0.100 |
Why?
|
Social Class | 1 | 2021 | 2008 | 0.100 |
Why?
|
Antibody Affinity | 1 | 2013 | 252 | 0.100 |
Why?
|
Regression Analysis | 4 | 2016 | 6340 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1014 | 0.100 |
Why?
|
Caregivers | 2 | 2022 | 2302 | 0.100 |
Why?
|
Maternal Health Services | 1 | 2017 | 472 | 0.100 |
Why?
|
Goals | 1 | 2017 | 717 | 0.100 |
Why?
|
Seroepidemiologic Studies | 1 | 2013 | 404 | 0.100 |
Why?
|
Pneumonia | 2 | 2013 | 2163 | 0.090 |
Why?
|
Wounds and Injuries | 3 | 2012 | 2517 | 0.090 |
Why?
|
Fever | 1 | 2019 | 1614 | 0.090 |
Why?
|
Emotions | 3 | 2021 | 2767 | 0.090 |
Why?
|
Immunocompromised Host | 1 | 2017 | 863 | 0.090 |
Why?
|
Dehydration | 2 | 2024 | 216 | 0.090 |
Why?
|
Delivery, Obstetric | 1 | 2018 | 954 | 0.090 |
Why?
|
Family Planning Services | 1 | 2014 | 279 | 0.090 |
Why?
|
Vitamin B Complex | 1 | 2013 | 299 | 0.090 |
Why?
|
Family | 1 | 2021 | 3209 | 0.090 |
Why?
|
Parity | 1 | 2014 | 931 | 0.090 |
Why?
|
Health Surveys | 2 | 2018 | 4057 | 0.090 |
Why?
|
Perinatal Mortality | 1 | 2010 | 103 | 0.090 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4055 | 0.080 |
Why?
|
Ascorbic Acid | 1 | 2013 | 658 | 0.080 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2010 | 361 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1892 | 0.080 |
Why?
|
Ghana | 2 | 2022 | 333 | 0.080 |
Why?
|
Social Behavior | 1 | 2016 | 1147 | 0.080 |
Why?
|
Hepatitis C | 1 | 2020 | 1595 | 0.080 |
Why?
|
Infant Food | 2 | 2019 | 139 | 0.080 |
Why?
|
Body Weights and Measures | 2 | 2019 | 208 | 0.080 |
Why?
|
Cluster Analysis | 3 | 2021 | 2732 | 0.080 |
Why?
|
Learning | 3 | 2024 | 1759 | 0.080 |
Why?
|
Immunization Schedule | 1 | 2010 | 228 | 0.080 |
Why?
|
Adiposity | 1 | 2019 | 1895 | 0.080 |
Why?
|
Vitamin E | 1 | 2013 | 874 | 0.080 |
Why?
|
Cost-Benefit Analysis | 4 | 2022 | 5536 | 0.080 |
Why?
|
Students | 1 | 2019 | 1744 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2020 | 10760 | 0.070 |
Why?
|
Mortality | 1 | 2019 | 2911 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3109 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2023 | 4568 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2012 | 2923 | 0.070 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1169 | 0.070 |
Why?
|
Cost of Illness | 1 | 2016 | 1951 | 0.070 |
Why?
|
Risk Assessment | 4 | 2024 | 24315 | 0.070 |
Why?
|
Hospitalization | 2 | 2016 | 10840 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4045 | 0.060 |
Why?
|
Disability Evaluation | 1 | 2012 | 1835 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2022 | 4818 | 0.060 |
Why?
|
Respiratory Function Tests | 1 | 2009 | 1695 | 0.060 |
Why?
|
Malaria | 1 | 2014 | 1249 | 0.060 |
Why?
|
Forced Expiratory Volume | 1 | 2009 | 1831 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2019 | 81762 | 0.050 |
Why?
|
Interviews as Topic | 2 | 2019 | 2741 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2015 | 3980 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13090 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 202 | 0.050 |
Why?
|
Child Nutrition Sciences | 1 | 2020 | 22 | 0.050 |
Why?
|
Isoniazid | 1 | 2022 | 288 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6874 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2009 | 1886 | 0.040 |
Why?
|
Aged | 6 | 2022 | 171504 | 0.040 |
Why?
|
Diarrhea, Infantile | 1 | 2020 | 100 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 2 | 2024 | 3231 | 0.040 |
Why?
|
Acute Disease | 2 | 2021 | 7243 | 0.040 |
Why?
|
Cause of Death | 1 | 2010 | 3721 | 0.040 |
Why?
|
Length of Stay | 1 | 2013 | 6498 | 0.040 |
Why?
|
MEDLINE | 1 | 2019 | 119 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
Edema | 1 | 2023 | 765 | 0.040 |
Why?
|
Spouses | 1 | 2021 | 286 | 0.040 |
Why?
|
Orosomucoid | 1 | 2018 | 45 | 0.040 |
Why?
|
Food, Fortified | 1 | 2019 | 189 | 0.040 |
Why?
|
Arm | 1 | 2021 | 591 | 0.040 |
Why?
|
Exercise | 3 | 2019 | 5955 | 0.040 |
Why?
|
Nutritional Sciences | 1 | 2019 | 148 | 0.040 |
Why?
|
Colombia | 1 | 2019 | 287 | 0.040 |
Why?
|
Pregnancy in Adolescence | 1 | 2019 | 166 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 59629 | 0.040 |
Why?
|
Diet Surveys | 1 | 2021 | 1160 | 0.040 |
Why?
|
Vomiting | 1 | 2020 | 655 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1737 | 0.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2018 | 416 | 0.030 |
Why?
|
Trace Elements | 1 | 2017 | 193 | 0.030 |
Why?
|
Minerals | 1 | 2017 | 282 | 0.030 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2019 | 542 | 0.030 |
Why?
|
Protoporphyrins | 1 | 2016 | 168 | 0.030 |
Why?
|
Child Behavior | 1 | 2021 | 864 | 0.030 |
Why?
|
Economics | 1 | 2016 | 141 | 0.030 |
Why?
|
Term Birth | 1 | 2016 | 140 | 0.030 |
Why?
|
Health Resources | 1 | 2021 | 950 | 0.030 |
Why?
|
Pregnancy Trimester, First | 1 | 2019 | 917 | 0.030 |
Why?
|
Diet Records | 1 | 2016 | 426 | 0.030 |
Why?
|
Latin America | 1 | 2016 | 416 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2023 | 2204 | 0.030 |
Why?
|
Asia | 1 | 2016 | 629 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2016 | 300 | 0.030 |
Why?
|
Family Characteristics | 1 | 2019 | 1003 | 0.030 |
Why?
|
Disabled Children | 1 | 2017 | 250 | 0.030 |
Why?
|
Pregnancy, Multiple | 1 | 2015 | 216 | 0.030 |
Why?
|
Zinc Sulfate | 1 | 2013 | 18 | 0.030 |
Why?
|
Birth Order | 1 | 2014 | 93 | 0.030 |
Why?
|
Databases, Factual | 1 | 2009 | 8080 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1397 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2017 | 638 | 0.030 |
Why?
|
Placenta | 1 | 2022 | 1725 | 0.030 |
Why?
|
Violence | 1 | 2019 | 936 | 0.030 |
Why?
|
United States | 2 | 2019 | 73039 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2124 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2014 | 506 | 0.030 |
Why?
|
Food Supply | 1 | 2019 | 544 | 0.030 |
Why?
|
Indonesia | 1 | 2012 | 131 | 0.030 |
Why?
|
Empirical Research | 1 | 2012 | 119 | 0.030 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 914 | 0.020 |
Why?
|
Attention | 1 | 2022 | 2424 | 0.020 |
Why?
|
Parent-Child Relations | 1 | 2017 | 772 | 0.020 |
Why?
|
Prognosis | 1 | 2013 | 30010 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2019 | 22291 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2021 | 2783 | 0.020 |
Why?
|
Bangladesh | 1 | 2012 | 742 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 20227 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3886 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 1534 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3288 | 0.020 |
Why?
|
Medication Adherence | 1 | 2020 | 2187 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2020 | 3205 | 0.020 |
Why?
|
Psychometrics | 1 | 2017 | 3063 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1197 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13290 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9613 | 0.010 |
Why?
|
Internet | 1 | 2012 | 3110 | 0.010 |
Why?
|
Animals | 2 | 2021 | 169246 | 0.010 |
Why?
|
Health Policy | 1 | 2010 | 2698 | 0.010 |
Why?
|